A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—First Results

Czajka, Hanna; Zapolnik, Paweł; Krzych, Łukasz; Kmiecik, Wojciech; Stopyra, Lidia; Nowakowska, Anna; Jackowska, Teresa; Darmochwał-Kolarz, Dorota; Szymański, Henryk; Radziewicz-Winnicki, Igor; Mazur, Artur

doi:10.3390/vaccines10020314

Public

A Multi-Center, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—First Results

Shared by NobleBlocks on Feb 17, 2022 • 12:00 AM UTC

Authors:

Hanna Czajka

Paweł Zapolnik

Łukasz Krzych

Abstract

Tuberculosis vaccines (Bacillus Calmette-Guérin, BCG) were introduced 100 years ago and are still recommended by the World Health Organization to prevent the disease. Studies have shown that BCG vaccination can stimulate non-specific immune responses and reduce the incidence of certain diseases. At ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!